Companies: 10,795·Total market cap: $144.5T
Impact BioMedical Inc.

Impact BioMedical Inc.

IBOAMEXHealthcare● Active
$0.56
$-0.00(-0.84%)
Market Cap$6937500
P/E Ratio—
52W High$1.95
52W Low$0.362
SEC Filings

Impact BioMedical Inc. (IBO) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001834105 · IBO · AMEX · as of Jun 9, 2026

Filing snapshot

136
Total Filings
10-Q
Latest Form
2026-05-12
Most Recent
2024
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001834105 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-11
Fiscal Year End
Mar 11, 2026
Accession No.
0001493152-26-009711
Primary Document
form10-k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001834105 · Accession 0001493152-26-009711

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-12
View 10-Q on SEC
8-KCurrent Report
8-K
2026-03-04Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
10-QQuarterly Report
10-Q
2026-05-12
View
S-8 POSS-8 POS
S-8 POS
2026-04-22
View
S-8 POSS-8 POS
S-8 POS
2026-04-06
View
10-KAnnual Report
10-K
2026-03-11
View
8-KCurrent Report
8-K
2026-03-04
View
DEF 14CDEF 14C
DEF 14C
2025-12-30
View
PRE 14CPRE 14C
PRE 14C
2025-12-11
View
10-QQuarterly Report
10-Q
2025-11-07
View
8-KCurrent Report
8-K
2025-11-06
View
8-KCurrent Report
8-K
2025-10-27
View
DEF 14AProxy Statement
DEF 14A
2025-09-22
View
DEF 14CDEF 14C
DEF 14C
2025-09-09
View
PRE 14CPRE 14C
PRE 14C
2025-08-25
View
10-QQuarterly Report
10-Q
2025-08-14
View
DEF 14CDEF 14C
DEF 14C
2025-08-05
View
Showing 1–15 of 119 filingsForm 4 / 144 hidden· 136 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001834105  |  Exchange: AMEX · Healthcare

Impact BioMedical Inc. (AMEX: IBO) has submitted 136 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2024. As a Healthcare sector company with CIK 0001834105, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Impact BioMedical Inc.'s most comprehensive regulatory disclosure. The most recent Impact BioMedical Inc. 10-K was filed on 2026-03-11 for fiscal year ending 2026. Historical IBO 10-K annual reports are available from 2021 through 2026.

Investors researching Impact BioMedical Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
NRSN SEC Filings →CYCN SEC Filings →BCLI SEC Filings →XBIO SEC Filings →XTLB SEC Filings →MLEC SEC Filings →TCRT SEC Filings →QNRX SEC Filings →
→ IBO Financials→ IBO Earnings→ IBO Insider Trades

Frequently Asked Questions

IBO SEC Filings · 8 questions

Impact BioMedical Inc. (IBO) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 136 filings and access original documents at no cost. Impact BioMedical Inc.'s CIK is 0001834105.

IBO SEC filingsImpact BioMedical Inc. SEC documentsfind IBO 10-K